C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2011
05/19/2011	WO2011028579A3 Aligning cells on wrinkled surface
05/19/2011	WO2011002926A3 Isolated adult cells, artificial organs,rehabilitated organs, research rools, organ encasements, organ perfusion systems, and methods for preparing and utilizing the same
05/19/2011	WO2010148334A3 Generation of induced pluripotent stem cells from cord blood
05/19/2011	WO2010148275A3 Bioreactor system
05/19/2011	WO2010056328A9 Isolated renal cells and uses thereof
05/19/2011	WO2010040526A8 Lcmv-gp-vsv-pseudotyped vectors and tumor-infiltrating virus-producing cells for the therapy of tumors
05/19/2011	US20110119795 Artificial plant minichromosomes
05/19/2011	US20110119794 Rice non-endosperm tissue expression promoter (ostsp 1) and the use thereof
05/19/2011	US20110119793 Chimeric promoters and their uses thereof in Plants
05/19/2011	US20110119791 Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants
05/19/2011	US20110119787 Fructan biosynthetic enzymes
05/19/2011	US20110119786 Inositol polyphosphate 2-kinase genes and uses thereof
05/19/2011	US20110119785 Nucleotide sequences and corresponding polypeptides conferring modulated growth rate and biomass in plants grown in saline and oxidative conditions
05/19/2011	US20110119784 Cotton Variety FM 1845LLB2
05/19/2011	US20110119782 Construct capable of release in closed circular form from a larger nucleotide sequence permitting site specific expression and/or developmentally regulated expression of selected genetic sequences
05/19/2011	US20110119781 Compositions and Methods for Inhibiting Expression of TGF-BETA Receptor Genes
05/19/2011	US20110119780 Screening for non-genotoxic carcinogens
05/19/2011	US20110119779 Methods for sequential replacement of targeted region by homologous recombination
05/19/2011	US20110119778 Steganographic embedding of information in coding genes
05/19/2011	US20110119777 Use of aav replication machinery for improved protein production
05/19/2011	US20110119775 Hydrazide-containing cftr inhibitor compounds and uses thereof
05/19/2011	US20110118456 Interfering RNA Molecules
05/19/2011	US20110118446 Methods and compositions for antibody production
05/19/2011	US20110118445 Inhibitor protein of the wnt signal pathway
05/19/2011	US20110118444 Binding molecules
05/19/2011	US20110118337 Method of Using Compositions Comprising MIR-192 and/or MIR-215 for the Treatment of Cancer
05/19/2011	US20110118336 Microrna-21 antagonists and its target PDCD4 for use in the treatment of a glioma
05/19/2011	US20110118296 Bis-Carbazole DNA Intercalating Agents for Antitumor Therapy
05/19/2011	US20110118281 Compounds for inflammation and immune-related uses
05/19/2011	US20110118248 Heteroaryl sulfonamides and CCR2/CCR9
05/19/2011	US20110118233 Certain Substituted Amides, Method of Making, and Method of Use Thereof
05/19/2011	US20110118228 Enzymatic production or chemical synthesis and uses for 5,7-dienes and UVB conversion products thereof
05/19/2011	US20110118193 Treatment of liquid cancers
05/19/2011	US20110118181 Pcsk9 inhibitors and methods of use thereof
05/19/2011	US20110117652 Somatic embryogenesis of jatropha curcas from ovules
05/19/2011	US20110117651 Cell adhesion promoting agent and method of promoting cell adhesion
05/19/2011	US20110117650 Vessel and method for isolating cells from tissue portions
05/19/2011	US20110117649 Catalytic enantioselective synthesis of flavanones and chromanones
05/19/2011	US20110117648 Single cell surgery tool and a cell transfection device utilizing the photothermal properties of thin films and/or metal nanoparticles
05/19/2011	US20110117647 Red Blood Cell Storage Medium For Extended Storage
05/19/2011	US20110117646 Antisense modulation of c-reactive protein expression
05/19/2011	US20110117645 Method for proliferation of pluripotent stem cells
05/19/2011	US20110117644 DR5 gene promoter and SIAH-1 gene promoter
05/19/2011	US20110117627 Regulation of apoptosis by neural specific splice variants of ig20
05/19/2011	US20110117608 Double-stranded nucleic acid
05/19/2011	US20110117596 Composite sorbent material, its preparation and its use
05/19/2011	US20110117575 Isolation and/or identification of stem cells having adipocytic, chondrocytic and pancreatic differentiation potential
05/19/2011	US20110117521 Biological regenerate
05/19/2011	US20110117204 Immunologically active compositions
05/19/2011	US20110117185 Methods for treating or preventing heart damage with integrin-linked kinase (ilk) compositions
05/19/2011	US20110117181 Treating hepatitis c virus infection with over-expression of microrna-196
05/19/2011	US20110117171 Implantable bone graft materials
05/19/2011	US20110117169 Methods and compositions for capture of cells
05/19/2011	US20110117167 Methods and compositions for soft tissue repair
05/19/2011	US20110117163 Bioactive coating for an implantable device or bioprosthesis
05/19/2011	US20110117162 Isolated Renal Cells and Uses Thereof
05/19/2011	US20110117141 Methods and compositions comprising novel cationic lipids
05/19/2011	US20110117137 Tapasin augmentation for enhanced immune response
05/19/2011	US20110117135 Method of Forming Dendritic Cells from Embryonic Stem Cells
05/19/2011	US20110117125 Compositions and methods for the delivery of nucleic acids
05/19/2011	US20110117117 Novel immunogenic epitopes for immunotherapy
05/19/2011	US20110117112 Sodium channel protein type iii alpha-subunit splice variant
05/19/2011	US20110117110 Anti-egfr antibodies and their uses
05/19/2011	US20110117109 Cytomegalovirus disintegrin-like peptides
05/19/2011	US20110117104 Monoclonal antibody specific to anthrax toxin
05/19/2011	US20110117103 Anti-sweat antigen monoclonal antibody
05/19/2011	US20110117101 Cc chemokine receptor 5 dna, new animal models and therapeutic agents for hiv infection
05/19/2011	US20110117093 Antibodies that immunospecifically bind to b lymphocyte stimulator protein
05/19/2011	US20110117086 Monoclonal antibodies to progastrin and their uses
05/19/2011	US20110117081 Functionalized pyrrolidines and use thereof as iap inhibitors
05/19/2011	US20110117080 Anti-REG4 Antibodies
05/19/2011	US20110117079 Therapeutic dll4 binding proteins
05/19/2011	US20110117072 Hyperactive variants of the transposase protein of the transposon system sleeping beauty
05/19/2011	US20110117069 Method for activating regulatory t-cells
05/19/2011	US20110117067 Glucanases, Nucleic Acids Encoding Them and Methods for Making and Using Them
05/19/2011	US20110117066 Established human brown adipocyte line and method for differentiation from an hmads cell line
05/19/2011	US20110117065 Compositions and methods for using cells to treat heart tissue
05/19/2011	US20110117063 Methods For Producing Enriched Populations of Human Retinal Pigment Epithelium Cells For Treatment of Retinal Degeneration
05/19/2011	US20110117062 Methods For Producing Enriched Populations of Human Retinal Pigment Epithelium Cells
05/19/2011	US20110117061 Ex Vivo Expansion of Human Hematopoietic Stem Cells
05/19/2011	US20110117051 Method for inducing and accelerating cells
05/19/2011	US20110117049 Methods and Compositions for Modulating Adipocyte Function
05/19/2011	US20110117039 Antioxidant, anti-inflammatory or anti-aging composition containing taxus cambium- or procambium-derived cell line as active ingredient
05/19/2011	US20110117026 Methods and compositions for the delivery of bioactive compounds
05/19/2011	US20110117017 Peptides with properties of an allosteric antagonist selective for the alpha 1a adrenergic receptor and uses thereof
05/19/2011	US20110117011 Neutralizing proprotein convertase subtilisin kexin type 9 (pcsk9) variants and uses thereof
05/19/2011	CA2783437A1 Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
05/19/2011	CA2780726A1 Method for generation and regulation of ips cells and compositions thereof
05/19/2011	CA2780573A1 Device and method for culturing cells
05/19/2011	CA2780549A1 Subpopulations of spore-like cells and uses thereof
05/19/2011	CA2780541A1 Methods and compositions for expanding, identifying, characterizing and enhancing potency of mammalian-derived glial restricted progenitor cells
05/19/2011	CA2780490A1 Hydrogel-based vascular lineage cell growth media and uses thereof
05/19/2011	CA2780430A1 Genes differentially expressed by cumulus cells and assays using same to identify pregnancy competent oocytes
05/19/2011	CA2778817A1 Pluripotent stem cells
05/18/2011	EP2322933A1 Diagnosis of carcinomas
05/18/2011	EP2322668A2 Highly conserved gene and its use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes for microorganisms.
05/18/2011	EP2322667A2 Highly conserved gene and its use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes for microorganisms.
05/18/2011	EP2322666A2 Highly conserved gene and its use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes for microorganisms.
05/18/2011	EP2322644A1 Methods for producing modified glycoproteins
05/18/2011	EP2322635A2 Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof

1 ... 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 ... 1827